(Press-News.org) SAN ANTONIO -- Surgically opening the windpipe, or trachea, within the first seven days of the start of mechanical ventilation decreases the time patients spend on ventilators, shortens their ICU stay and lowers their risk of ventilator-associated pneumonia, according to a systematic review published Thursday (March 11) in JAMA Otolaryngology-Head & Neck Surgery.
"We analyzed the existing medical literature to unravel a question that is very pertinent to adult critical care," said senior author Alvaro Moreira, MD, MSc, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio). "At what point should surgeons open the trachea in critical care patients to most benefit them?"
The surgery, called tracheotomy, is performed either in the operating room or at the bedside, depending on patient risk factors. The team analyzed 17 studies that included more than 3,000 patients. The systematic review compared early versus late tracheotomy, with "early" defined as being performed seven days or shorter after initiation of ventilation and "late" defined as eight days or longer, including patients who never required a tracheotomy.
Outcomes
Early tracheotomy was associated with improvement in three major clinical outcomes: ventilator-associated pneumonia (40% reduction in risk), ventilator-free days (1.7 additional days off the ventilator, on average) and ICU stay (6.3 days shorter time in unit, on average). Doing the procedure early did not impact patient mortality, however.
Patients receiving mechanical ventilation are intubated and breathe through a tube extending down into their windpipe. After 48 hours of intubation, patients in critical care units are at higher risk to develop ventilator-associated pneumonia, Dr. Moreira said.
A tracheostomy is placed for patient comfort, to wean the patient off sedatives and to increase the speed with which the patient can come off the ventilator.
"One of the hesitations for families is that their critically ill loved one is undergoing an intervention," Dr. Moreira said. "But if the patient were to develop pneumonia, that would increase their hospital stay and, in some patients, could be deadly.
"It's therefore a fine balance that providers and families need to consider when evaluating whether a patient is a good candidate for the intervention."
Implications for pandemic
Although no patients in the study were COVID-positive, the findings have potential translation to hospital critical care during the pandemic.
In March 2020, a committee of the American Academy of Otolaryngology-Head & Neck Surgery advised health care workers to "avoid performing tracheotomy in COVID-19 positive or suspected patients during periods of respiratory instability or heightened ventilator dependence." The committee said tracheotomy could be considered "in patients with stable pulmonary status but should not take place sooner than two to three weeks from the time of intubation and, preferably, with negative COVID-19 testing."
Since that time, studies have demonstrated that tracheotomy can be safely done in a negative pressure room, with proper personal protective equipment, sedation of the patient and frequent suctioning of the site.
"When investigators followed the health care providers for a month, they found that the clinicians did not contract COVID-19 when proper precautions were taken," Dr. Moreira said.
Different professional societies now state that COVID-19 patients should be considered like other patients. However, the timing of tracheostomy placement in this population is still up for debate.
Dr. Moreira is a professor in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio. Coauthors are from the University of Pennsylvania Perelman School of Medicine and the Long School of Medicine.
INFORMATION:
Impact of Early vs. Late Tracheotomy Placement on Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-Analysis
Kevin Chorath, MD; Ansel Hoang, BS; Karthik Rajasekaran, MD; Alvaro Moreira, MD, MSc
First published: March 11, 2021, JAMA Otolaryngology-Head & Neck Surgery
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2777173
The END
The global battle against antibiotic resistance can only succeed if local contexts are taken into account. "A tailored approach is needed in each country," says Heiman Wertheim of Radboud university medical center. "There is no "one-size-fits-all' solution." This was the main finding of a study on antibiotic resistance in African and Asian countries funded by the British Wellcome Trust. Wertheim is the lead investigator of a large group of international researchers who recently published an article on this study in The Lancet Global Health.
Antibiotics are powerful treatments for bacterial infections. They are indispensable for controlling infections such as pneumonia, meningitis, or blood poisoning (sepsis) caused by bacteria. But they are ineffective for treating ...
Sugar has been called "evil," "toxic," and "poison." But the body needs sugars, too. Sugar molecules help cells recognize and fight viruses and bacteria, shuttle proteins from cell to cell, and make sure those proteins function. Too much or too little can contribute to a range of maladies, including neurodegenerative diseases like Alzheimer's, inflammation, diabetes, and even cancer.
About 85 percent of proteins, including those associated with Alzheimer's and Parkinson's, are beyond the reach of current drugs. One critical and abundant sugar (O-GlcNAc, pronounced o-glick-nack) is found on over 5,000 proteins, often those considered "undruggable." But now, researchers at Harvard University ...
Boston, MA - Vaccinating adults age 26 and older against the human papillomavirus (HPV)--the virus that causes more than 90% of cervical cancers as well as several other cancers--may not be cost-effective, according to a new study led by researchers at the Harvard T.H. School of Public Health.
"Our study found that the added health benefit of increasing the vaccination age limit beyond 26 years is minimal, and that the cost-effectiveness is much lower than in pre-adolescents, the target age group for the HPV vaccine," said Jane Kim, K.T. Li Professor of Health Economics and lead author of the study.
The study will be published March 11, 2021, in PLOS Medicine.
HPV vaccines have been shown to be highly effective in preventing ...
Eating is a dangerous business. Naturally occurring toxins in food and potentially harmful foodborne microbes can do a number on our intestines, leading to repeated minor injuries. In healthy people, such damage typically heals in a day or two. But in people with Crohn's disease, the wounds fester, causing abdominal pain, bleeding, diarrhea and other unpleasant symptoms.
Researchers at Washington University School of Medicine in St. Louis and the Cleveland Clinic have discovered that a fungus found in foods such as cheese and processed meats can infect sites of intestinal damage in mice and people with Crohn's and prevent healing. Moreover, treating infected mice with antifungal medication eliminates the fungus and allows the wounds ...
Insights into how bacterial proteins work as a network to take control of our cells could help predict infection outcomes and develop new treatments.
Much like a hacker seizes control of a company's software to cause chaos, disease-causing bacteria, such as E. coli and Salmonella, use miniature molecular syringes to inject their own chaos-inducing agents (called effectors) into the cells that keep our guts healthy.
These effectors take control of our cells, overwhelming their defences and blocking key immune responses, allowing the infection to take hold.
Previously, studies have investigated single effectors. Now a team led by scientists at Imperial College London and The Institute of Cancer ...
A team led by Christoph Utschick and Prof. Rudolf Gross, physicists at the Technical University of Munich (TUM), has developed a coil with superconducting wires capable of transmitting power in the range of more than five kilowatts contactless and with only small losses. The wide field of conceivable applications include autonomous industrial robots, medical equipment, vehicles and even aircraft.
Contactless power transmission has already established itself as a key technology when it comes to charging small devices such as mobile telephones and electric toothbrushes. Users would also like to see contactless charging made available for larger electric machines such as industrial robots, medical equipment and electric vehicles.
Such devices could ...
How do you turn "dumb" headphones into smart ones? Rutgers engineers have invented a cheap and easy way by transforming headphones into sensors that can be plugged into smartphones, identify their users, monitor their heart rates and perform other services.
Their invention, called END ...
Irvine, Calif., March 11, 2021 - Catastrophic collapse of materials and structures is the inevitable consequence of a chain reaction of locally confined damage - from solid ceramics that snap after the development of a small crack to metal space trusses that give way after the warping of a single strut.
In a study published this week in Advanced Materials, engineers at the University of California, Irvine and the Georgia Institute of Technology describe the creation of a new class of mechanical metamaterials that delocalize deformations to prevent failure. They did so by turning to tensegrity, a century-old design principle in which isolated ...
LAWRENCE -- Much like coronavirus, circulating HIV-1 viruses mutate into diverse variants that pose challenges for scientists developing vaccines to protect people from HIV/AIDS.
"AIDS vaccine development has been a decades-long challenge partly because our immune systems have difficulty recognizing all the diverse variants of the rapidly mutating HIV virus, which is the cause of AIDS," said Brandon DeKosky, assistant professor of pharmaceutical chemistry and chemical & petroleum engineering at the University of Kansas.
In the past five years, tremendous progress has been ...
Philadelphia, March 12, 2021 - Researchers from Children's Hospital of Philadelphia (CHOP) have determined what happens at a cellular level as the lung alveolus forms and allows newborns to breathe air. Understanding this process gives researchers a better sense of how to develop therapies and potentially regenerate this critical tissue in the event of injury. The findings were published online today by the journal Science.
The lung develops during both embryonic and postnatal stages, during which lung tissue forms and a variety of cell types perform specific roles. During the transition from embryo to newborn is when the alveolar region of the lung ...
